Prolonged Response to First-Line Erlotinib for Advanced Lung Adenocarcinoma
Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/1756-9966-27-59
Full Text
Open PDFAbstract
Available in full text
Date
November 4, 2008
Authors
Publisher
Springer Science and Business Media LLC